Table 2.
Comparison of patient indicators
| Item | SLE-SH (n = 41) | SLE-ES (n = 315) | SLE-CH (n = 7) |
|---|---|---|---|
| 24 h urine protein (g/d) | 1.76 ± 0.28 | 1.64 ± 0.31 | 1.87 ± 0.3.26 |
| Anti-dsDNA antibodies, n (%) | 31 (75.6) | 242 (76.8) | 6 (85.7) |
| Anti-Sm antibodies, n (%) | 12 (29.3) | 94 (29.8) | 2 (28.6) |
| ESR (mm/h) | 43.7 ± 11.8 | 47.8 ± 12.8 | 44.9 ± 12.2 |
| CRP (mg/L) | 8.71 ± 2.32 | 7.95 ± 2.44 | 8.46 ± 2.27 |
| C3 (g/L) | 0.51 ± 0.25 | 0.46 ± 0.24 | 0.49 ± 0.26 |
| SLEDAI | 9.14 ± 3.67 | 8.75 ± 3.28 | 8.47 ± 3.86 |
| PGA | 62.50 ± 18.94 | 63.43 ± 19.33 | 64.58 ± 20.12 |
| SLICC | 5.5 ± 1.7 | 5.7 ± 1.5 | 5.9 ± 1.7 |
ESR, Erythrocyte Sedimentation Rate; CRP, C-reactive protein; SLEDAI, systemic lupus erythematosus disease activity index; PGA, patient’s global assessment; SLICC, Systemic Lupus International Collaborating Clinics and the American College of Rheumatology Diagnostic and Therapeutic Criteria Committee Damage Index.